Literature DB >> 19089300

Inhibition of Lux quorum-sensing system by synthetic N-acyl-L-homoserine lactone analogous.

Wenzhao Wang1, Tomohiro Morohoshi, Tsukasa Ikeda, Liang Chen.   

Abstract

In the present study, we investigated the inhibition of the Lux quorum-sensing system by N-acyl cyclopentylamine (Cn-CPA). The Lux quorum-sensing system regulates luminescence gene expression in Vibrio fischeri. We have already reported on the synthesis of Cn-CPA and their abilities as inhibitors of the quorum-sensing systems in Pseudomonas aeruginosa and Serratia marcescens. In the case of Pseudomonas aeruginosa (Las and Rhl quorum-sensing system) and Serratia marcescens (Spn quorum-sensing system), specific Cn-CPA with a particular acyl chain length showed the strongest inhibitory effect. In the case of the Lux quorum-sensing system, it was found that several kinds of Cn-CPA with a range from C5 to C10 showed similar strong inhibitory effects. Moreover, the inhibitory effect of Cn-CPA on the Lux quorum-sensing system was stronger than that of halogenated furanone, a natural quorum-sensing inhibitor.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19089300     DOI: 10.1111/j.1745-7270.2008.00490.x

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  3 in total

Review 1.  Productive steps toward an antimicrobial targeting virulence.

Authors:  Amy K Barczak; Deborah T Hung
Journal:  Curr Opin Microbiol       Date:  2009-07-22       Impact factor: 7.934

2.  In Silico Screening and Analysis of Broad-Spectrum Molecular Targets and Lead Compounds for Diarrhea Therapy.

Authors:  Harriet U Ugboko; Obinna C Nwinyi; Solomon U Oranusi; Toluwase H Fatoki; Paul A Akinduti; Jesupemi M Enibukun
Journal:  Bioinform Biol Insights       Date:  2019-10-24

3.  Repurposing anti-diabetic drug "Sitagliptin" as a novel virulence attenuating agent in Serratia marcescens.

Authors:  Hisham A Abbas; Wael A H Hegazy
Journal:  PLoS One       Date:  2020-04-16       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.